|1.||Glück, R: 3 articles (10/2002 - 03/2000)|
|2.||Cusi, M G: 2 articles (10/2002 - 06/2000)|
|3.||Valassina, M: 2 articles (10/2002 - 06/2000)|
|4.||Valensin, P E: 2 articles (10/2002 - 06/2000)|
|5.||Wei, Wei-Zen: 1 article (02/2014)|
|6.||Aurisicchio, Luigi: 1 article (02/2014)|
|7.||Peruzzi, Daniela: 1 article (02/2014)|
|8.||Ciliberto, Gennaro: 1 article (02/2014)|
|9.||Koo, Gloria: 1 article (02/2014)|
|10.||La Monica, Nicola: 1 article (02/2014)|
|1.||Human Influenza (Influenza)
10/04/2002 - "In the present study we investigated the efficacy of a new potential vaccine constituted of the respiratory syncytial virus (RSV)-F protein associated with influenza virosomes (RSV-F/IRIV) in combination with the mucosal adjuvant Escheriagen (Escherichia coli heat-labile toxin), administered intranasally (i.n.) to BALB/c mice. "
04/06/2001 - "Previously, we demonstrated that the recombinant B subunit of the Escherichia coli heat-labile toxin (LTB) is a potent adjuvant towards nasally administered influenza subunit antigen. "
06/15/2000 - "The mucosal vaccination strategy against influenza has been investigated by using influenza virosomal vaccine (IRIV) combined with two different adjuvants: the procholeragenoid (PCG) and the Escherichia coli heat labile toxin (HLT). "
04/01/1994 - "Cholera toxin B subunit (CTB) and Escherichia coli heat-labile toxin (LTB) (2 micrograms), each supplemented with a trace amount of cholera toxin (CT) (0.02-20 ng), were examined for the adjuvant effect on antibody (Ab) response against influenza inactivated HA (haemagglutinin) vaccine in Balb/c mice. "
03/01/2000 - "A trivalent influenza virosome vaccine containing hemagglutinin and Escherichia coli heat-labile toxin (HLT) was administered intranasally to young adults and elderly subjects. "
04/01/1983 - "The clinical disease seen in the babies was not characteristic of previously described E coli heat-labile toxin-associated diarrhea."
01/01/2002 - "Intranasal immunization of mice with a chimeric VP6 protein and the mucosal adjuvant Escherichia coli heat labile toxin LT(R192G) induces nearly complete protection against murine rotavirus (strain EDIM [epizootic diarrhea of infant mice virus]) shedding for at least 1 year. "
06/01/2000 - "Cholera toxin (CT) and Escherichia coli heat-labile toxin (LT) are not only the causative agents of diarrhea but are also strong mucosal adjuvants which enhance immune responses to mucosally coadministered bystander antigens. "
|3.||Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
|4.||Whooping Cough (Pertussis)
12/01/2003 - "The cholera-like enterotoxins (CLETS), cholera toxin (CT) and Escherichia coli heat-labile toxin (LT), are powerful mucosal adjuvants. "
04/01/1994 - "Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine."
|3.||Adenosine Diphosphate (ADP)
|5.||Immunoglobulin A (IgA)
|7.||A-Form DNA (A-DNA)
|8.||Influenza Vaccines (FluMist)
|9.||Immunoglobulin G (IgG)